Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
SPINRAZA Royalties Revenue	221.90M	216.10M	240.40M
SPINRAZA Royalties Revenue Growth	2.68%	-10.11%	-0.78%
WAINUA Royalties Revenue	43.00M	20.20M	-
WAINUA Royalties Revenue Growth	112.87%	-	-
TEGSEDI and WAYLIVRA Revenue	36.90M	34.20M	34.90M
TEGSEDI and WAYLIVRA Revenue Growth	7.90%	-2.01%	15.95%
Commercial Licensing and Other Royalty Revenue	78.60M	22.60M	33.30M
Commercial Licensing and Other Royalty Revenue Growth	247.79%	-32.13%	7.42%
Total Commercial Revenue	380.40M	293.10M	308.60M
Total Commercial Revenue Growth	29.79%	-5.02%	1.71%
Amortization from Upfront Payments Revenue	-	131.40M	125.30M
Amortization from Upfront Payments Revenue Growth	-	4.87%	82.65%
Milestone Payments Revenue	-	106.40M	100.50M
Milestone Payments Revenue Growth	-	5.87%	35.81%
R&D License Fees Revenue	-	71.30M	116.80M
R&D License Fees Revenue Growth	-	-38.95%	215.68%
Other R&D Services Revenue	-	23.50M	10.00M
Other R&D Services Revenue Growth	-	135.00%	-63.77%
Collaborative Agreement Revenue	510.00M	332.60M	352.60M
Collaborative Agreement Revenue Growth	53.34%	-5.67%	70.17%
Eplontersen Joint Development Revenue	76.40M	79.40M	126.40M
Eplontersen Joint Development Revenue Growth	-3.78%	-37.18%	64.58%
Total R&D Revenue	586.40M	412.00M	479.00M
Total R&D Revenue Growth	42.33%	-13.99%	68.66%
Revenue (Other)	-629.24M	-432.16M	-478.95M
Revenue (Total)	966.96M	705.14M	787.65M
Revenue (Total) Growth	37.13%	-10.47%	34.10%

Updated Sep 30, 2025. Data Source: Fiscal.ai.